Nations unite in fight against childhood leukemia with new personalized treatment plan
Disease control
Recruiting now
This study aims to improve survival and quality of life for children and young adults (ages 0-45) newly diagnosed with acute lymphoblastic leukemia (ALL). It brings together leading European research groups to test a new, personalized treatment plan that adjusts therapy based on …
Sponsor: Mats Heyman • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC